485 related articles for article (PubMed ID: 18416448)
21. General statistical design considerations of randomized clinical trials.
Peduzzi P
Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
[TBL] [Abstract][Full Text] [Related]
22. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found.
Detsky AS; Sackett DL
Arch Intern Med; 1985 Apr; 145(4):709-12. PubMed ID: 3985731
[TBL] [Abstract][Full Text] [Related]
23. Sample size and the probability of a successful trial.
Chuang-Stein C
Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
[TBL] [Abstract][Full Text] [Related]
24. Mid-course sample size modification in clinical trials based on the observed treatment effect.
Jennison C; Turnbull BW
Stat Med; 2003 Mar; 22(6):971-93. PubMed ID: 12627413
[TBL] [Abstract][Full Text] [Related]
25. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
26. Estimating sample size in clinical studies: basic methodological principles.
Carneiro AV
Rev Port Cardiol; 2003 Dec; 22(12):1513-21. PubMed ID: 15008067
[TBL] [Abstract][Full Text] [Related]
27. Power and sample size.
Case LD; Ambrosius WT
Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
[TBL] [Abstract][Full Text] [Related]
28. The role of the minimum clinically important difference and its impact on designing a trial.
Chuang-Stein C; Kirby S; Hirsch I; Atkinson G
Pharm Stat; 2011; 10(3):250-6. PubMed ID: 20936625
[TBL] [Abstract][Full Text] [Related]
29. Stopping clinical trials early for benefit: impact on estimation.
Freidlin B; Korn EL
Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
[TBL] [Abstract][Full Text] [Related]
30. Sample size estimation for non-inferiority trials of time-to-event data.
Crisp A; Curtis P
Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
[TBL] [Abstract][Full Text] [Related]
31. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.
Sahai H; Khurshid A
Stat Med; 1996 Jan; 15(1):1-21. PubMed ID: 8614740
[TBL] [Abstract][Full Text] [Related]
32. Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity.
Anand SP; Murray SC; Koch GG
J Biopharm Stat; 2010 May; 20(3):587-603. PubMed ID: 20358438
[TBL] [Abstract][Full Text] [Related]
33. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
34. Standard versus adaptive monitoring procedures: A commentary.
Fleming TR
Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
[TBL] [Abstract][Full Text] [Related]
35. An investigation of clinical studies suggests those with multiple objectives should have at least 90% power for each endpoint.
Borm GF; Houben RM; Welsing PM; Zielhuis GA
J Clin Epidemiol; 2006 Jan; 59(1):1-6. PubMed ID: 16360554
[TBL] [Abstract][Full Text] [Related]
36. Inadequate statistical power of negative clinical trials in urological literature.
Breau RH; Carnat TA; Gaboury I
J Urol; 2006 Jul; 176(1):263-6. PubMed ID: 16753417
[TBL] [Abstract][Full Text] [Related]
37. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
38. A simple method for calculating power based on a prior trial.
Borm GF; Bloem BR; Munneke M; Teerenstra S
J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
[TBL] [Abstract][Full Text] [Related]
39. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials.
Chen H; Zhang N; Lu X; Chen S
Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405
[TBL] [Abstract][Full Text] [Related]
40. A note on the power of Fisher's least significant difference procedure.
Meier U
Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
